Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	449.05	468.13	480.89	375.69	394.91	329.02
Other Revenue	0.57	0.57	2.95	5.16	2.9	4.07
Revenue	449.62	468.7	483.84	380.84	397.81	333.09
Revenue Growth (YoY)	1.20%	-3.13%	27.05%	-4.26%	19.43%	-9.92%
Cost of Revenue	186.86	196.94	208.34	160.6	178.89	139.21
Gross Profit	262.76	271.75	275.5	220.24	218.92	193.88
Selling, General & Admin	91.02	92.63	84.26	81.84	76.15	56.91
Research & Development	74.44	79.63	77.07	77.88	72.29	55.64
Other Operating Expenses	-3.09	-2.68	-3.43	-4.3	-2.49	-2.01
Operating Expenses	163.73	171.29	161.48	154.02	146.68	111.67
Operating Income	99.03	100.47	114.02	66.22	72.24	82.21
Interest Expense	-0.23	-0.38	-0.36	-0.11	-0.07	-
Interest & Investment Income	38.83	37.32	29.6	16.43	19.59	27.82
Currency Exchange Gain (Loss)	10.48	10.48	5.49	26.13	-6.02	-8.54
Other Non Operating Income (Expenses)	-1.36	-0.63	-0.38	-0.38	-0.37	-0.27
EBT Excluding Unusual Items	146.74	147.26	148.36	108.29	85.37	101.22
Gain (Loss) on Sale of Investments	-0.22	0.17	2.93	-1.37	0.43	-
Gain (Loss) on Sale of Assets	5.13	4.61	2.96	-0.5	30.26	0.01
Asset Writedown	-1.21	-	-	-0.51	-1.59	-
Other Unusual Items	4.01	4.8	7.94	9.22	10.08	10.28
Pretax Income	154.45	156.85	162.19	115.13	124.54	111.51
Income Tax Expense	18.43	16.34	15.71	9.29	12.07	11.88
Net Income	136.02	140.51	146.48	105.84	112.47	99.64
Net Income to Common	136.02	140.51	146.48	105.84	112.47	99.64
Net Income Growth	31.47%	-4.08%	38.40%	-5.89%	12.88%	-5.23%
Shares Outstanding (Basic)	111	112	110	113	112	112
Shares Outstanding (Diluted)	111	112	110	113	112	112
Shares Change (YoY)	1.53%	1.25%	-2.19%	0.11%	0.79%	28.88%
EPS (Basic)	1.22	1.26	1.33	0.94	1.00	0.89
EPS (Diluted)	1.22	1.26	1.33	0.94	1.00	0.89
EPS Growth	29.49%	-5.26%	41.49%	-6.00%	12.00%	-26.47%
Free Cash Flow	129.75	131.83	51.9	11.53	0.78	51.56
Free Cash Flow Per Share	1.16	1.18	0.47	0.10	0.01	0.46
Dividend Per Share	1.000	1.000	0.800	0.700	0.357	0.571
Dividend Growth	25.00%	25.00%	14.29%	96.02%	-37.50%	-20.01%
Gross Margin	58.44%	57.98%	56.94%	57.83%	55.03%	58.21%
Operating Margin	22.02%	21.44%	23.57%	17.39%	18.16%	24.68%
Profit Margin	30.25%	29.98%	30.28%	27.79%	28.27%	29.91%
Free Cash Flow Margin	28.86%	28.13%	10.73%	3.03%	0.19%	15.48%
EBITDA	109.99	111.73	125.68	78.3	81.53	90.4
EBITDA Margin	24.46%	23.84%	25.97%	20.56%	20.50%	27.14%
D&A For EBITDA	10.96	11.26	11.66	12.07	9.29	8.19
EBIT	99.03	100.47	114.02	66.22	72.24	82.21
EBIT Margin	22.02%	21.44%	23.57%	17.39%	18.16%	24.68%
Effective Tax Rate	11.93%	10.42%	9.69%	8.07%	9.69%	10.65%
Revenue as Reported	449.62	468.7	483.84	380.84	397.81	333.09
Advertising Expenses	-	5.27	3.38	2.64	4.1	4.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.